Cobenfy

Active Ingredient(s): Trospium Chloride + Xanomeline Tartrate
FDA Approved: * September 26, 2024
Pharm Company: * BRISTOL-MYERS
Category: Antipsychotic
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Cobenfy Oral Capsule, Coated Pellets

NDC: 0003-0050

Labeler:

E.r. Squibb & Sons, L.L.C.

Cobenfy Oral Capsule, Coated Pellets

NDC: 0003-0125

Labeler:

E.r. Squibb & Sons, L.L.C.

Cobenfy Oral Capsule, Coated Pellets

NDC: 0003-1100

Labeler:

E.r. Squibb & Sons, L.L.C.

CobenfyCobenfy Kit

NDC: 0003-5150

Labeler:

E.r. Squibb & Sons, L.L.C.

CobenfyCobenfy Kit

NDC: 0003-5200

Labeler:

E.r. Squibb & Sons, L.L.C.